There are 172,089,484 on issue due to expire in April 16. If all...

There are 172,089,484 on issue due to expire in April 16. If all are converted $3,441,789 minus costs will be added to cl8's working capital not 2 million.

The Equity facility is in essence a C.R. Funds are received, new shares are issued. It's not set up as a loan facility. Might be worth thinking about next time you go calling shareholders 'newbies'

Interestingly hishenk and noble investment hold a significant amount of options, some of these were issued freely. If we can get a Vwap at or above 2.3c and require further funding it may force them to convert options rather than dilute the shares further outside of the option on issue.

Even if they do become CF+ in the near future I would not be discounting further C.R. (Or draw downs on the 'equity facility' if you like) to drive growth or entering new markets, to say otherwise is unfounded.

At the end of the day, they are in a much better place than 12 months ago. I'm more than happy to be invested in this company.

IMO dyor